Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 11, 2013, Pages 1375-1389

  Zhang, Jiong ^a   Pippin, Jeffrey W ^a   Krofft, Ronald D ^a   Naito, Shokichi ^a   Liu, Zhi Hong ^b   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; CD44; Focal segmental glomerulosclerosis; Glomerulosclerosis; Parietal epithelial cell; Prednisone; Proteinuria; Regeneration; Repair

Indexed keywords

CASPASE 3; PREDNISONE; SYNAPTOPODIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWMAN CAPSULE; CELL COUNT; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; IMMUNOMODULATION; JUXTAGLOMERULAR CELL; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY STEM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; STAINING;

EID: 84878665612     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00020.2013     Document Type: Article

References (45)

1. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ. Recuitment of podocytes from glomer-ular parietal epithelial cells. J Am Soc Nephrol 20: 333-343, 2009.
2. Bariety J, Mandet C, Hill GS, Bruneval P. Parietal podocyte in normal human glomeruli. J Am Soc Nephrol 17: 2770-2780, 2006.
3. Benigni A, Morigi M, Remuzzi G. Kidney regeneration. Lancet 375: 1310-1317, 2010.
4. Benigni A, Morigi M, Rizzo P, Gagliardini E, Rota C, Abbate M, Ghezzi S, Remuzzi A, Remuzzi G. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 179: 628-638, 2011.
5. Brinkkoetter PT, Olivier P, Wu JS, Henderson S, Krofft RD, Pippin JW, Hockenbery D, Roberts JM, Shankland SJ. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest 119: 3089-3101, 2009.
6. Brinkkoetter PT, Wu JS, Ohse T, Krofft RD, Schermer B, Benzing T, Pippin JW, Shankland SJ. P35, the noncyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney Int 77: 690-699, 2010.
7. Chang AM, Ohse T, Krofft RD, Wu JS, Eddy AA, Pippin JW, Shankland SJ. Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2. Neph-rol Dial Transplant 27: 1330-1343, 2012.
8. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 365: 2398-2411, 2011.
9. Darisipudi MN, Kulkarni OP, Sayyed SG, Ryu M, Migliorini A, Sagrinati C, Parente E, Vater A, Eulberg D, Klussmann S, Romag-nani P, Anders HJ. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol 179: 116-124, 2011.
10. Fatima H, Moeller MJ, Smeets B, Yang HC, D'Agati VD, Alpers CE, Fogo AB. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 7: 1852-1858, 2012.
11. Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 22: 2011-2022, 2007.
12. Fogo AB. The target podocyte. J Clin Invest 121: 2142-2145, 2011.
13. Fujii Y, Khoshnoodi J, Takenaka H, Hosoyamada M, Nakajo A, Bessho F, Kudo A, Takahashi S, Arimura Y, Yamada A, Nagasawa T, Ruotsalainen V, Tryggvason K, Lee AS, Yan K. The effect of dexa-methasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int 69: 1350-1359, 2006.
14. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R, Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA, Inoki K, Wiggins RC. Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 23: 1351-1363, 2012.
15. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC. Angiotensin II-dependent persistent podocyte loss from destabilized glom-eruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012.
16. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D'Agati VD, Friedman AL. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80: 868-878, 2011.
17. Griffin SV, Krofft RD, Pippin JW, Shankland SJ. Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney Int 67: 977-986, 2005.
18. Hiromura K, Haseley LA, Zhang P, Monkawa T, Durvasula R, Petermann AT, Alpers CE, Mundel P, Shankland SJ. Podocyte expression of the CDK inhibitor p57 during development and disease. Kidney Int 60: 2235-2246, 2001.
19. Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol 8: 211-218, 2013.
20. Hunter MG, Hurwitz S, Bellamy CO, Duffield JS. Quantitative mor-phometry of lupus nephritis: the significance of collagen, tubular space, and inflammatory infiltrate. Kidney Int 67: 94-102, 2005.
21. Korbet SM. Treatment of primary FSGS in adults. J Am Soc Nephrol 23: 1769-1776, 2012.
22. Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazz-inghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 28: 1674-1685, 2010.
23. Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney Int 72: 489-498, 2007.
24. Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, Grattarola M, Pugliese F, Pesce C, Pugliese G. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabe-tologia 50: 2591-2599, 2007.
25. Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, Hudkins KL, Alpers CE, Pippin JW, Shankland SJ. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol 298: F702-F711, 2010.
26. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54: 416-425, 1998.
27. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009.
28. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE. Gluco-corticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68: 2473-2483, 2005.
29. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296, 2006.
30. Romagnani P, Remuzzi G. Renal progenitors in nondiabetic and diabetic nephropathies. Trends Endocrinol Metab 24: 13-20, 2013.
31. Romagnani P. Parietal epithelial cells: their role in health and disease. Contrib Nephrol 169: 23-36, 2011.
32. Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol 9: 137-146, 2013.
33. Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20: 322-332, 2009.
34. Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P. Isolation and characterization of multipotent progenitor cells from the Bwoman's capsule of adult human kidneys. J Am Soc Nephrol 17: 2443-2456, 2006.
35. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Böttinger EP. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001.
36. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006.
37. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Gröne HJ, Floege J, Moeller MJ. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262-1274, 2011.
38. Taniguchi Y, Pippin JW, Hagmann H, Krofft RD, Chang AM, Zhang J, Terada Y, Brinkkoetter P, Shankland SJ. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Am J Physiol Renal Physiol 302: F1161-F1171, 2012.
39. Vaughan MR, Pippin JW, Griffin SV, Krofft R, Fleet M, Haseley L, Shankland SJ. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 68: 133-144, 2005.
40. Wada T, Pippin JW, Marshal CB, Griffin SV, Shankland SJ. Dexa-methasone prevents podocyte apoptosis induced by puromycin amino-nucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16: 2615-2625, 2005.
41. Wada T, Pippin JW, Nangaku M, Shankland SJ. Dexamethasone's prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron Exp Nephrol 109: e8-e19, 2008.
42. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007.
43. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int 70: 1038-1045, 2006.
44. Zhang J, Hansen KM, Pippin JW, Chang AM, Taniguchi Y, Krofft RD, Pickering SG, Liu ZH, Abrass CK, Shankland SJ. De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy. Am J Physiol Renal Physiol 302: F571-F580, 2012.
45. Zhang J, Pippin JW, Vaughan MR, Krofft RD, Taniguchi Y, Romag-nani P, Nelson PJ, Liu ZH, Shankland SJ. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. Nephron Exp Nephrol 121: e23-e37, 2012.